🇺🇸 FDA

Drug profile · INN

sincalide

SINCALIDE

approved
US status
approved
Patents linked
3
News articles
0

Quick answer

sincalide (SINCALIDE) is an FDA-listed pharmaceutical active ingredient. Associated with MAIA Biotechnology. Route of administration: intravenous. Current US regulatory status: approved.

Key facts

INN sincalide
Brand SINCALIDE
Route INTRAVENOUS
Formulation POWDER
Originator MAIA Biotechnology

Related patents

Search patents →

  1. US 11737983

    Storage stable sincalide formulations

    Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11318100

    Storage stable sincalide formulations

    Expires Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11110063

    Storage stable sincalide formulations

    Expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is sincalide?

sincalide (SINCALIDE) is an FDA-listed pharmaceutical active ingredient. Associated with MAIA Biotechnology. Route of administration: intravenous. Current US regulatory status: approved.

What is the brand name for sincalide?

SINCALIDE is a marketed brand name for sincalide. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of sincalide?

sincalide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.